BactiQuant (BACTIQ.CO) Stock Analysis & AI Equity Report

Industrial - Pollution & Treatment Controls DKK Explore free reports

BactiQuant (BACTIQ.CO) overview

BactiQuant (BACTIQ.CO) stock analysis and AI equity research. For the latest completed financial year, 2025, BactiQuant reported revenue of DKK 8.3m and operating profit of DKK -12.5m; the year-end share price was 3.30 DKK and market capitalisation was DKK 98.3m. BactiQuant is covered by Valuatum but does not yet have a published AI equity report. Generate a fresh report to get BactiQuant's valuation, segment value analysis, reverse valuation, financial forecasts, key ratios, risks and catalysts.

Key metrics & valuation multiples

Book valueDKK 17.3mFY 2025
Share price3.30 DKKFY 2025 year end
RevenueDKK 8.3mFY 2025
Operating profitDKK -12.5mFY 2025
Net earningsDKK -13.8mFY 2025
Market capitalisationDKK 98.3mFY 2025 year end

Figures updated on 2026-07-27. Data will be refreshed during report generation.

About BactiQuant

BactiQuant A/S develops and sells technology for measuring and monitoring bacterial levels in water. Its product range includes online systems and handheld mobile lab solutions used in water utilities, industrial processes, pharmaceuticals, aquaculture, and other water-dependent operations. The company’s value drivers are rapid bacterial detection, improved water quality control, and reduced waste.

Generate the BactiQuant report

BactiQuant is on Valuatum's coverage list, but a full AI equity report hasn't been generated yet. Order one now for the complete company value map, reverse valuation, risk & catalyst analysis, and financial statements and estimates — plus a downloadable PDF.

Generate fresh report — €50.00 Delivered by email, typically within about 30 minutes

Sources & methodology

Financial figures are sourced from Valuatum's financial model for BactiQuant and represent the latest completed financial year (2025). See the methodology for the full Valuatum AI equity research framework.

Disclaimer: This is an AI-generated research material for informational purposes only. It is not investment advice or a buy/sell recommendation. Always perform your own analysis. Valuatum Oy, Helsinki, Finland.

Analyst reports on BactiQuant

Each is this company's Valuatum report re-run with an analyst's own assumptions and published under their name. They are ordered by what other analysts said the work added over the engine's report — a score out of five from people who had to read it to give it.